• Home
  1. Home
  2. Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration
Scientific article
English

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration

ContributorsChatzidionysiou, Katerina; Lie, Elisabeth; Lukina, Galina; Hetland, Merete L; Hauge, Ellen-Margrethe; Pavelka, Karel; Gabay, Cem; Scherer, Almut; Nordström, Dan; Canhao, Helena; Santos, Maria José; Tomsic, Matija; Rotar, Ziga; Hernández, M Victoria; Gomez-Reino, Juan; Ancuta, Ioan; Kvien, Tore K; van Vollenhoven, Ronald
Published inJournal of Rheumatology, vol. 44, no. 2, p. 162-169
Publication date2017
Abstract

Several aspects of rituximab (RTX) retreatment in rheumatoid arthritis (RA) need to be further elucidated. The aim of this study was to describe the effect of repeated courses of RTX on disease activity and to compare 2 retreatment strategies, fixed-interval versus on-flare retreatment, in a large international, observational, collaborative study.

Keywords
  • Adult
  • Aged
  • Antirheumatic Agents/therapeutic use
  • Arthritis, Rheumatoid/diagnosis/drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Registries
  • Retreatment
  • Rituximab/therapeutic use
  • Severity of Illness Index
  • Treatment Outcome
Affiliation entities
Research groups
Citation (ISO format)
CHATZIDIONYSIOU, Katerina et al. Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration. In: Journal of Rheumatology, 2017, vol. 44, n° 2, p. 162–169. doi: 10.3899/jrheum.160460
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0315-162X
437views
1downloads

Technical informations

Creation03/09/2018 11:04:00
First validation03/09/2018 11:04:00
Update24/01/2025 14:28:17
Status update24/01/2025 14:28:17
Last indexation24/01/2025 14:36:42
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack